Literature DB >> 7693380

Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction.

D Hamilton-Fairley1, D Kiddy, V Anyaoku, R Koistinen, M Seppälä, S Franks.   

Abstract

OBJECTIVE: We determined the relationship of short-term changes in circulating insulin concentrations, resulting from an oral glucose load, to those in both sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein 1 (IGFBP-1) and assessed the effect of a short-term low calorie diet on the levels of SHBG and IGFBP-1 during an oral glucose tolerance test.
DESIGN: A within-group comparison of biochemical indices during an oral glucose tolerance test before and after calorie restriction. PATIENTS AND METHODS: Six obese women with polycystic ovary syndrome with mean (SD) BMI 34.2 (3.4) kg/m2 were studied before and after one month on a very low calorie diet (350 kcal/day; Cambridge diet). Each subject was given a 75-g oral glucose load after an overnight fast and blood samples were taken every 30 minutes for 3 hours. These were analysed for glucose, insulin, SHBG, and IGFBP-1.
RESULTS: All the women lost weight (range 1.7-9.5 kg). The SHBG concentrations did not change significantly during the oral glucose tolerance test but there was a highly significant decline in IGFBP-1 levels both before (0 min, mean (SD) 27.3 (10.6); 180 min, 8.9 (4.2) micrograms/l) and after (0 min, 28.4 (12.1); 180 min, 6.2 (2.1) micrograms/l, P < 0.001) dieting. The sum of the SHBG concentrations during the test, however, was significantly lower prior (129.9 (40.5) nmol/l) to calorie restriction than after (164.3 (70.6) nmol/l), whereas there was no significant effect of dieting on the IGFBP-1 response to glucose.
CONCLUSIONS: The changes in insulin and SHBG concentrations found after dieting have been confirmed. SHBG levels, in contrast to IGFBP-1, do not change in response to a short-term increase in insulin or glucose concentrations. The difference in the response of the two binding proteins may be explained by differences in their half-lives in the circulation or the regulation of mRNA for the peptides by insulin. This study confirms that insulin regulates both SHBG and IGFBP-1 but that there is a difference in the time course of the response of the two proteins to insulin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693380     DOI: 10.1111/j.1365-2265.1993.tb02378.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

1.  The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study.

Authors:  Sedigheh Ghandi; Abbas Aflatoonian; Nasim Tabibnejad; Mohammad Hossein Sojoodi Moghaddam
Journal:  J Assist Reprod Genet       Date:  2011-04-12       Impact factor: 3.412

2.  The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.

Authors:  S Jafari-Sfidvajani; R Ahangari; M Hozoori; H Mozaffari-Khosravi; H Fallahzadeh; A Nadjarzadeh
Journal:  J Endocrinol Invest       Date:  2017-11-06       Impact factor: 4.256

Review 3.  Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan.

Authors:  H Teede; A Deeks; L Moran
Journal:  BMC Med       Date:  2010-06-30       Impact factor: 8.775

4.  Pharmacological and non-pharmacological strategies for obese women with subfertility.

Authors:  Seyed Abdolvahab Taghavi; Madelon van Wely; Shayesteh Jahanfar; Fatemeh Bazarganipour
Journal:  Cochrane Database Syst Rev       Date:  2021-03-25

5.  Efficacy of Bariatric Surgery in the Treatment of Women With Obesity and Polycystic Ovary Syndrome.

Authors:  Lili Hu; Li Ma; Xinyi Xia; Tao Ying; Minzhi Zhou; Shuhua Zou; Haoyong Yu; Jun Yin
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

6.  Effects of chronic exposure to low doses of trichloroethylene on steroid hormone and insulin levels in normal men.

Authors:  V H Goh; S E Chia; C N Ong
Journal:  Environ Health Perspect       Date:  1998-01       Impact factor: 9.031

7.  The characterization of obese polycystic ovary syndrome rat model suitable for exercise intervention.

Authors:  Chuyan Wu; Feng Lin; Shuwei Qiu; Zhongli Jiang
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

8.  Current trends in the treatment of polycystic ovary syndrome with desire for children.

Authors:  Margalida E Sastre; Maria O Prat; Miguel Angel Checa; Ramon C Carreras
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

9.  Effects of orlistat on serum androgen levels among iranian obese women with polycystic ovarian syndrome.

Authors:  Saghar Salehpour; Sedighe Hosseini; Leila Nazari; Nasrin Saharkhiz; Shahrzad Zademodarres
Journal:  JBRA Assist Reprod       Date:  2018-09-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.